Nebula Biocides raises €1.6M Seed round
10 November 2021· Greifswald, Germany· health, medtech, biotech, b2b, deep_hardware
The funding is intended to support the regulatory approval process for the Sporosan® disinfection technology as a biocidal product and medical device, finance required studies, and enable product development and market penetration.
Investors
LeadHigh-Tech Gründerfonds
Also participating
Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern mbH
About Nebula Biocides
Stage
Seed
Headquarters
Greifswald, Germany
Founded
2019
Team Size
6–20
Sectors
healthmedtechbiotechb2bdeep_hardware
Source: https://www.htgf.de/en/htgf-investment-nebula-biocides/